Navigation Links
Spiral Flow(TM) Grafts Enhance Patient Outcomes - New Paper Published in the Prestigious 'Annals of Vascular Surgery'
Date:7/6/2012

DUNDEE, Scotland, July 6, 2012 /PRNewswire/ --

The medium term results of a 'First in Man' structured registry study are due to be published in the October issue of the Annals of Vascular Surgery. This significant paper describes a 40 patient, 10 centre study by leading vascular surgeons and doctors on patients with peripheral arterial disease needing an above-the-knee or below-the-knee bypass graft.

Peripheral arterial disease affects up to 20% of people over the age of 70. Patients are at high risk for cardiovascular events in the future, especially those needing bypass surgery. Improvements in bypass surgery techniques and devices are therefore very significant and a large number of people could benefit. This study demonstrates the validity of the concept of Spiral Laminar Flow(TM). It shows patient outcomes equivalent to, or exceeding, any known prosthetic grafts, including Heparin bonded grafts.

Vascular Flow Technologies is a medical device company operating within the peripheral vascular market. Its revolutionary and unique Spiral Laminar Flow(TM) technology re-establishes natural blood flow patterns in peripheral vascular and arteriovenous grafts - helping to keep damaged blood vessels open for longer and improving outcomes for patients.

Bill Allan, CEO, says, "We are very pleased to see this high quality study published in a prestigious journal and are encouraged by the key findings within the paper. It's clear that Spiral Flow(TM) Grafts enhance patient outcomes. We will continue to develop more clinical experience and data sets and look forward to wider awareness of the true impact of our Spiral Flow(TM) products on patients' lives."

For more information:

Call: +44-(0)1382-598-532 E-mail: news@vascular-flow.com Visit: http://www.vascular-flow.com

 

For more press information contact:

Bill Allan: +44-(0)7920-143-030 Kate Full: +44-(0)1382-598-532 Caroline Thoms: +44-(0)1382-598-532


'/>"/>
SOURCE Vascular Flow Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Nano spiral staircases modify light
2. Blocked holes can enhance rather than stop light going through
3. Auxilium Announces Appointments to Enhance Leadership Team
4. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
5. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
6. McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance
7. Bio-inspired polymer synthesis enhances structure control
8. BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research
9. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
10. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
11. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Vyriad Inc. announced today the appointment of ... Directors. "We are delighted to welcome Al ... develop our oncolytic viruses as the next generation of ... , MD, PhD, CEO of Vyriad. "Al and his ... passion for making a difference for cancer patients—their philanthropy ...
(Date:12/7/2016)... BOULDER, Colo. , Dec. 7, 2016  Muse ... genome engineering technologies, today announced that Dr. Kevin ... member of the Board of Directors. ... , who becomes the company,s Chief Science Officer as ... and Executive Director of the BioDesign Center at the ...
(Date:12/7/2016)... -- Regen BioPharma Inc. (OTCQB: RGBPP) In a ... a team of scientists in Guangzhou, China ... expression of NR2F6 in patients with early cervical cancer correlates ... cervical cancer tissue as well as in the normal tissue ... interesting study and the first that I am aware of ...
Breaking Biology Technology:
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the company ... Life Sciences Awards as "Most Outstanding in eClinical ... year of recognition and growth for MedNet, which has ... iMedNet ™ , MedNet,s flagship ...
Breaking Biology News(10 mins):